WSE-bound biotech company OncoArendi Therapeutics set its IPO price at PLN 29 apiece and will sell 2 million shares, all that it planned to float. This puts the value of the IPO at PLN 58 million, the company said. Individual investors will be able to acquire 140k shares, with the rest going to institutional investors….
- Poland AM
- Our Products